Liver Transplant Rejection

Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients

Safety of DNP007 in Healthy Subjects

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transplantation in Egyptian Patients.

Long-term Benefit of MPA in Liver Transplantation

The TOGETHER Project - Liver

TRU-IMMUNO: Optimizing Liver Immunosuppression

The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma

Mortality, Morbidity and Risk Factors of Liver Retransplantation

VOCs in Kidney and Liver Transplants

Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

MSC Therapy in Liver Transplantation

Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration

Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents

Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation